Federated Hermes, Inc. Molecular Templates, Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.54 $994 - $1,377	-2,551 Reduced 67.7%	1,217 $0
Q4 2022 Feb 13, 2023	BUY	$0.33 - $12.0 $322 - $11,736	978 Added 35.05%	3,768 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.68 - $11.25 $221 - $3,667	326 Added 13.23%	2,790 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $3.43 $1,995 - $8,451	2,464 New	2,464 $2,000
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $52,528 - $71,431	-9,088 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $46,278 - $73,619	5,918 Added 186.69%	9,088 $71,000
Q1 2021 May 13, 2021	BUY	$9.33 - $14.05 $16,299 - $24,545	1,747 Added 122.77%	3,170 $40,000
Q4 2020 Feb 12, 2021	BUY	$8.48 - $12.23 $12,067 - $17,403	1,423 New	1,423 $13,000
Q3 2020 Nov 12, 2020	SELL	$9.99 - $14.41 $1.13 Million - $1.64 Million	-113,504 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.28 - $17.63 $741,564 - $1.06 Million	60,388 Added 113.69%	113,504 $1.57 Million
Q1 2020 May 13, 2020	BUY	$11.31 - $18.26 $303,628 - $490,207	26,846 Added 102.19%	53,116 $706,000
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $169,178 - $373,296	26,270 New	26,270 $367,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.